Methenamine hippurate and Hypersensitivity - a phase IV clinical study of FDA data

Summary:

Hypersensitivity is reported as a side effect among people who take Methenamine hippurate (methenamine hippurate), especially for people who are female, 60+ old, also take Acetaminophen, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Hypersensitivity when taking Methenamine hippurate. It is created by eHealthMe based on reports of 1,085 people who have side effects when taking Methenamine hippurate from the FDA, and is updated regularly.

What is Methenamine hippurate?

Methenamine hippurate has active ingredients of methenamine hippurate. It is often used in urinary tract infection. eHealthMe is studying from 1,158 Methenamine hippurate users. Check the latest studies of Methenamine hippurate.

What is Hypersensitivity?

Hypersensitivity is found to be associated with 2,748 drugs and 2,913 conditions by eHealthMe. Check the latest studies of Hypersensitivity.

On Jul, 31, 2026

1,085 people reported to have side effects when taking Methenamine hippurate.
Among them, 23 people (2.12%) have Hypersensitivity.

Could Methenamine hippurate cause Hypersensitivity?

Among these 23 people:

What is the gender of people who have Hypersensitivity when taking Methenamine hippurate? *

female: 95.45 %
male: 4.55 %

What is the age of people who have Hypersensitivity when taking Methenamine hippurate? *

What are other drugs people take besides Methenamine hippurate? *

Acetaminophen: 8 people, 34.78%
Aspirin: 7 people, 30.43%
Vitamin C: 7 people, 30.43%
Trimethoprim: 7 people, 30.43%
Vitamin D3: 6 people, 26.09%
Gabapentin: 6 people, 26.09%
Fluticasone Propionate: 5 people, 21.74%
Fish Oil: 5 people, 21.74%
Bactrim: 5 people, 21.74%
Cranberry: 5 people, 21.74%

What are other side effects people have besides Hypersensitivity? *

Weight Increased: 7 people, 30.43%
Nausea And Vomiting: 6 people, 26.09%
Rashes (redness): 5 people, 21.74%
Nausea (feeling of having an urge to vomit): 5 people, 21.74%
Cough: 5 people, 21.74%
Haemorrhage (bleeding): 5 people, 21.74%
Loss Of Consciousness: 4 people, 17.39%
Otitis (ear infection): 4 people, 17.39%
Nail Disorder (disease of nail): 4 people, 17.39%
Muscle Aches (muscle pain): 4 people, 17.39%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 17.39%
Immunodeficiency Common Variable: 4 people, 17.39%
Glaucoma (increased fluid pressure in the eye with vision loss): 3 people, 13.04%
High Blood Cholesterol: 2 people, 8.70%
Sleep Disorder: 2 people, 8.70%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 8.70%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 2 people, 8.70%
Hair Loss: 2 people, 8.70%
Vulvovaginal Dryness: 1 person, 4.35%
Diarrhea: 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Methenamine hippurate and have Hypersensitivity?

- Check whether Hypersensitivity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Methenamine hippurate:

Methenamine hippurate (1,158 reports)

Hypersensitivity treatments and more:

Hypersensitivity (272,618 reports)

Browse all side effects of Methenamine hippurate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypersensitivity:

Hypersensitivity (2,748 drugs)

Browse all the conditions that are associated with Hypersensitivity:

Hypersensitivity (2,913 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methenamine hippurate (the active ingredients of Methenamine hippurate) and Methenamine hippurate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.